search
Back to results

L.Fermentum CECT5716 in Treatment of Breast Pain

Primary Purpose

Breast Pain

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Lactobacillus fermentum CECT5716
Placebo Comparator: maltodextrin
Sponsored by
Biosearch S.A.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breast Pain focused on measuring breast pain, probiotic, mastitis, lactobacillus fermentun, Staphylococcus

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

· breast-feeding women

  • Swelling and / or warmth in the chest
  • Chest pain
  • total bacteria count in milk greater than or equal to 3 log10 colony forming units (CFU) / mL,

Exclusion Criteria:

  • breast abscesses, Raynaud syndrome,
  • Antibiotic treatment
  • Allergic to antibiotics
  • Low expectation of compliance with the study protocol.

Sites / Locations

  • Hospital Virgen de las Nieves

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Placebo Comparator

Arm Label

fermentum 3x

fermentum 6x

fermentum 9x

maltodextrin

Arm Description

Lactobacillus fermentum CECT5716 at 3x10e9 cfu/day

Lactobacillus fermentum CECT5716 at 6x10e9cfu/day

Lactobacillus fermentum CECT5716 at 9x10e9cfu/day

maltodextrin

Outcomes

Primary Outcome Measures

Change from baseline Staphylococcus count at 3 weeks
Counts of Staphylococcus in breast milk

Secondary Outcome Measures

Change from baseline Streptococcus counts at 3 weeks
Streptococcus counts in breast milk
Change from Breast pain score at 3 weeks
evaluation of breast pain

Full Information

First Posted
July 18, 2013
Last Updated
March 19, 2014
Sponsor
Biosearch S.A.
Collaborators
Funding: The Agency of Innovation and Development of Andalusia, Statistical analysis: SEPLIN Soluciones Estadísticas
search

1. Study Identification

Unique Protocol Identification Number
NCT02093338
Brief Title
L.Fermentum CECT5716 in Treatment of Breast Pain
Official Title
Study of Intervention Nutritional, Multicenter, Randomized, Blind, Parallel Group to Evaluate the Efficacy of Lactobacillus Fermentum CECT5716 to Reduce the Load Bacterial in Potential Pathogens in Milk of Mothers With Breast Pain
Study Type
Interventional

2. Study Status

Record Verification Date
March 2014
Overall Recruitment Status
Completed
Study Start Date
July 2011 (undefined)
Primary Completion Date
April 2013 (Actual)
Study Completion Date
April 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Biosearch S.A.
Collaborators
Funding: The Agency of Innovation and Development of Andalusia, Statistical analysis: SEPLIN Soluciones Estadísticas

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The main objective of this intervention study is to evaluate the efficacy of Lactobacillus fermentum CECT5716 to reduce the presence in the milk of genera Staphylococcus and Streptococcus as risk factors for mastitis in women with breast pain
Detailed Description
Type of study Nutritional intervention study, multicenter, randomized, blinded, parallel group included 25 women per group Group 1: 3x109 cfu / day (n = 25) Group 2: 6x109 cfu / day (n = 25) Group 3: 9x109 cfu / day (n = 25) Group 4: placebo (n = 25) Statistical calculation of sample size. The calculation of sample size was calculated by the company SEPLIN Solutions Statistics. The primary endpoint was the bacterial count of in milk. The sample size obtained to observe a difference of 1 log10, with a power of 0.80 and a significance level of 0.05 was 20 volunteers per group. Randomization Randomization was performed using a list of random numbers generated by computer. Subjects will be randomized in a strictly sequential. If a subject is removed from the test, the number that was assigned randomization not be reused again. Overall design and outline of the study At visit 1 we require the informed consent of the patient. It will take the milk sample, we will review the implementation of the inclusion and exclusion criteria. Be randomized and explain the treatment guidelines to be followed, the data to be collected and medical appointments that must go (2 and 3 weeks). It will complete the pain assessment questionnaire (MQP) and nutrition survey. On visits 2, 3 and 4 corresponding to 1, 2 and 3 weeks of intervention will collect milk sample pain assessment survey and nutrition survey. Milk samples (5 mL) were collected aseptically in sterile tubes to be frozen immediately until analysis to be carried out within seven days. Intervention duration The intervention will last three weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Pain
Keywords
breast pain, probiotic, mastitis, lactobacillus fermentun, Staphylococcus

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
127 (Actual)

8. Arms, Groups, and Interventions

Arm Title
fermentum 3x
Arm Type
Experimental
Arm Description
Lactobacillus fermentum CECT5716 at 3x10e9 cfu/day
Arm Title
fermentum 6x
Arm Type
Experimental
Arm Description
Lactobacillus fermentum CECT5716 at 6x10e9cfu/day
Arm Title
fermentum 9x
Arm Type
Experimental
Arm Description
Lactobacillus fermentum CECT5716 at 9x10e9cfu/day
Arm Title
maltodextrin
Arm Type
Placebo Comparator
Arm Description
maltodextrin
Intervention Type
Dietary Supplement
Intervention Name(s)
Lactobacillus fermentum CECT5716
Intervention Type
Other
Intervention Name(s)
Placebo Comparator: maltodextrin
Intervention Description
Placebo
Primary Outcome Measure Information:
Title
Change from baseline Staphylococcus count at 3 weeks
Description
Counts of Staphylococcus in breast milk
Time Frame
0, 3 weeks
Secondary Outcome Measure Information:
Title
Change from baseline Streptococcus counts at 3 weeks
Description
Streptococcus counts in breast milk
Time Frame
0, 3 weeks
Title
Change from Breast pain score at 3 weeks
Description
evaluation of breast pain
Time Frame
0, 3 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: · breast-feeding women Swelling and / or warmth in the chest Chest pain total bacteria count in milk greater than or equal to 3 log10 colony forming units (CFU) / mL, Exclusion Criteria: breast abscesses, Raynaud syndrome, Antibiotic treatment Allergic to antibiotics Low expectation of compliance with the study protocol.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr. Miguel A Díaz López, Doctor
Organizational Affiliation
Gynecology Service of Virgen de las Nieves Hospital, Granada (Spain)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Virgen de las Nieves
City
Granada
ZIP/Postal Code
18012
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
32987448
Citation
Crepinsek MA, Taylor EA, Michener K, Stewart F. Interventions for preventing mastitis after childbirth. Cochrane Database Syst Rev. 2020 Sep 29;9(9):CD007239. doi: 10.1002/14651858.CD007239.pub4.
Results Reference
derived

Learn more about this trial

L.Fermentum CECT5716 in Treatment of Breast Pain

We'll reach out to this number within 24 hrs